Multiple Acyl-CoA Dehydrogenase Deficiency: Phenotypic and Genetic Features of a Malaysian Cohort
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Multiple acyl-CoA dehydrogenase deficiency (MADD) is an inherited disorder of fatty acid oxidation that causes lipid storage myopathy (LSM). This is the first report on MADD that describes the phenotypic and genetic features of a Malaysian cohort. Methods Among the >2,500 patients in a local muscle biopsy database, patients with LSM were identified and their genomic DNA were extracted from muscle samples and peripheral blood. All 13 exons of the electron-transfer flavoprotein dehydrogenase gene (ETFDH) were subsequently sequenced. Fifty controls were included to determine the prevalence of identified mutations in the normal population. Results Fourteen (82%) of the 17 LSM patients had MADD with ETFDH mutations. Twelve (86%) were Chinese and two were Malay sisters. Other unrelated patients reported that they had no relevant family history. Nine (64%) were females. The median age at onset was 18.5 years (interquartile range=16–37 years). All 14 demonstrated proximal limb weakness, elevated serum creatine kinase levels, and myopathic changes in electromyography. Three patients experienced a metabolic crisis at their presentation. Sanger sequencing of ETFDH revealed nine different variants/mutations, one of which was novel: c.998A>G (p.Y333C) in exon 9. Notably, 12 (86%) patients, including the 2 Malay sisters, carried a common c.250G>A (p.A84T) variant, consistent with the hotspot mutation reported in southern China. All of the patients responded well to riboflavin therapy. Conclusions Most of our Malaysian cohort with LSM had late-onset, riboflavin-responsive MADD with ETFDH mutations, and they demonstrated phenotypic and genetic features similar to those of cases reported in southern China. Furthermore, we report a novel ETFDH mutation and possibly the first ever MADD patients of Malay descent.
Abstract
Background and Purpose Multiple acyl-CoA dehydrogenase deficiency (MADD) is an inherited disorder of fatty acid oxidation that causes lipid storage myopathy (LSM). This is the first report on MADD that describes the phenotypic and genetic features of a Malaysian cohort. Methods Among the >2,500 patients in a local muscle biopsy database, patients with LSM were identified and their genomic DNA were extracted from muscle samples and peripheral blood. All 13 exons of the electron-transfer flavoprotein dehydrogenase gene (ETFDH) were subsequently sequenced. Fifty controls were included to determine the prevalence of identified mutations in the normal population. Results Fourteen (82%) of the 17 LSM patients had MADD with ETFDH mutations. Twelve (86%) were Chinese and two were Malay sisters. Other unrelated patients reported that they had no relevant family history. Nine (64%) were females. The median age at onset was 18.5 years (interquartile range=16–37 years). All 14 demonstrated proximal limb weakness, elevated serum creatine kinase levels, and myopathic changes in electromyography. Three patients experienced a metabolic crisis at their presentation. Sanger sequencing of ETFDH revealed nine different variants/mutations, one of which was novel: c.998A>G (p.Y333C) in exon 9. Notably, 12 (86%) patients, including the 2 Malay sisters, carried a common c.250G>A (p.A84T) variant, consistent with the hotspot mutation reported in southern China. All of the patients responded well to riboflavin therapy. Conclusions Most of our Malaysian cohort with LSM had late-onset, riboflavin-responsive MADD with ETFDH mutations, and they demonstrated phenotypic and genetic features similar to those of cases reported in southern China. Furthermore, we report a novel ETFDH mutation and possibly the first ever MADD patients of Malay descent.
참고문헌 (30)
- Liang WC, "State of the art in muscle lipid diseases", Acta Myol, 29, pp.351~356 (2010)
- Angelini C, "Spectrum of metabolic myopathies", Biochim Biophys Acta, 1852, pp.615~621 (2015)
- Burr ML, "Metabolic myopathies : a guide and update for clinicians", Curr Opin Rheumatol, 20, pp.639~647 (2008)
- Liang WC, "ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency", Neuromuscul Disord, 19, pp.212~216 (2009)
- Frerman FE, "Deficiency of electron transfer flavoprotein or electron transfer flavoprotein : ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts", Proc Natl Acad Sci U S A, 82, pp.4517~4520 (1985)
- Xi J, "Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency", J Inherit Metab Dis, 37, pp.399~404 (2014)
- Gempel K, "The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase(ETFDH)gene", Brain, 130(Pt 8), pp.2037~2044 (2007)
- Grünert SC, "Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency", Orphanet J Rare Dis, 9, pp.117~ (2014)
- Zhu M, "Riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency in 13 cases, and a literature review in mainland Chinese patients", J Hum Genet, 59, pp.256~261 (2014)
- Kuo YC, "A systematic review of late-onset and very-late-onset multiple acyl-coenzyme A dehydrogenase deficiency : cohort analysis and patient report from Taiwan", Neuromuscul Disord, 31, pp.218~225 (2021)
- Olsen RK, "ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency", Brain, 130(Pt 8), pp.2045~2054 (2007)
- Cornelius N, "Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency", Hum Mol Genet, 21, pp.3435~3448 (2012)
- Olsen RK, "Lipid-storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency", J Inherit Metab Dis, 27, pp.671~678 (2004)
- Auranen M, "Patient with multiple acyl-CoA dehydrogenation deficiency disease and FLAD1 mutations benefits from riboflavin therapy", Neuromuscul Disord, 27, pp.581~584 (2017)
- Mereis M, "Disorders of flavin adenine dinucleotide metabolism : MADD and related deficiencies", Int J Biochem Cell Biol, 132, pp.105899~ (2021)
- Er TK, "High resolution melting analysis facilitates mutation screening of ETFDH gene : applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency", Clin Chim Acta, 411, pp.690~699 (2010)
- Wen B, "Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations", J Neurol Neurosurg Psychiatry, 81, pp.231~236 (2010)
- Law LK, "Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency", Clin Chim Acta, 404, pp.95~99 (2009)
- Wang ZQ, "Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency(MADD)in southern China confirmed the most common ETFDH mutation and high carrier frequency of c. 250G>A", J Mol Med(Berl), 89, pp.569~576 (2011)
- Chen W, "Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency(MADD) : case reports and epidemiology of ETFDH gene mutations", BMC Neurol, 19, pp.330~ (2019)
- Wasant P, "Glutaric aciduria type 2, late onset type in Thai siblings with myopathy", Pediatr Neurol, 43, pp.279~282 (2010)
- Goh LL, "Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy : a case report", BMC Med Genomics, 11, pp.37~ (2018)
- Choi Y, "Predicting the functional effect of amino acid substitutions and indels", PLoS One, 7, pp.e46688~ (2012)
- Kumar P, "Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm", Nat Protoc, 4, pp.1073~1081 (2009)
- Kim YJ, "Clinical features of multiple acyl-CoA dehydrogenase deficiency with ETFDH variants in the first Korean cases", Ann Lab Med, 38, pp.616~618 (2018)
- Yamada K, "Clinical and molecular investigation of 37 Japanese patients with multiple acyl-CoA dehydrogenase deficiency : p. Y507D in ETFDH, a common Japanese variant, causes a mortal phenotype", Mol Genet Metab Rep, 33, pp.100940~ (2022)
- Staretz-Chacham O, "Multiple acyl-CoA dehydrogenase deficiency with variable presentation due to a homozygous mutation in a Bedouin tribe", Genes(Basel), 12, pp.1140~ (2021)
- "SNV: 4-158682269-G-A(GRCh38), gnomAD v4.0.0"[URL]
- "dbSNP: short genetic variations. Reference SNP (rs) report (rs121964954)"[URL]
- Liu XY, "A historical cohort study on the efficacy of glucocorticoids and riboflavin among patients with late-onset multiple acyl-CoA dehydrogenase deficiency", Chin Med J(Engl), 129, pp.142~146 (2016)